Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 240Neoplasm Metastasis 20Neoplasms 11Prostatic Neoplasms, Castration-Resistant 7Prostate Cancer Metastatic 7Metastatic Castration-resistant Prostate Cancer 5Pain 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Metastatic Castration-Resistant Prostate Cancer 3Testicular Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Multiple Myeloma 2Metastatic Castration Resistant Prostate Cancer 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2

Interventions

pembrolizumab 26lenvatinib 7belzutifan 5Saline Solution 4Docetaxel 4epacadostat 3enzalutamide 3enfortumab vedotin 3Surgical Procedures, Operative 3Prednisone 3Gemcitabine 3Cisplatin 3Paclitaxel 2Dexamethasone 2Calcium Dobesilate 2vinflunine 1pazopanib 1olaparib 1Sunitinib 1Prednisolone 1Oxaliplatin 1Fluorouracil 1Cystectomy 1Carboplatin 1Capecitabine 1CB-1158 1Bevacizumab 1Axitinib 1Albumin-Bound Paclitaxel 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × Prednisone × Genitourinary × Clear all
NCT03834506 2025-07-18

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Completed
1,030 enrolled 24 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834519 2025-05-18

KEYLYNK-010

Merck Sharp & Dohme LLC

Phase 3 Completed
793 enrolled 23 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡